| Literature DB >> 29091730 |
Alexander Bergstrom1, Andrew Katko1, Zach Adkins1, Jessica Hill1, Zishuo Cheng1, Mia Burnett1, Hao Yang1, Mahesh Aitha1, M Rachel Mehaffey2, Jennifer S Brodbelt2, Kamaleddin H M E Tehrani3, Nathaniel I Martin3, Robert A Bonomo4, Richard C Page1, David L Tierney1, Walter Fast5, Gerard D Wright6, Michael W Crowder1.
Abstract
Metallo-β-lactamases (MBLs) are a growing threat to the continued efficacy of β-lactam antibiotics. Recently, aspergillomarasmine A (AMA) was identified as an MBL inhibitor, but the mode of inhibition was not fully characterized. Equilibrium dialysis and metal analysis studies revealed that 2 equiv of AMA effectively removes 1 equiv of Zn(II) from MBLs NDM-1, VIM-2, and IMP-7 when the MBL is at micromolar concentrations. Conversely, 1H NMR studies revealed that 2 equiv of AMA remove 2 equiv of Co(II) from Co(II)-substituted NDM-1, VIM-2, and IMP-7 when the MBL/AMA are at millimolar concentrations. Our findings reveal that AMA inhibits the MBLs by removal of the active site metal ions required for β-lactam hydrolysis among the most clinically significant MBLs.Entities:
Keywords: IMP-7; NDM-1; VIM-2; antibiotic resistance; aspergillomarasmine A; metallo-β-lactamase
Mesh:
Substances:
Year: 2017 PMID: 29091730 PMCID: PMC5807211 DOI: 10.1021/acsinfecdis.7b00106
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.084